Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 221-230 of 255 (Search time: 0.022 seconds).

  Effect of rosuvastatin on low density lipoprotein (LDL) profile in patients with primary dyslipidaemia (Journal article)

  Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB (Journal article)

  Basic and clinical aspects of platelet integrin alphaIIbbeta3 receptor antagonists in acute coronary syndromes (Journal article)

  Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia (Journal article)

  Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome: Comparison With Clopidogrel Hydrogen Sulfate (Journal article)

  Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis (Journal article)

  Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  The lipophilic modification of flavonol glucosides significantly influences their inhibitory potency towards LDL oxidation (Journal article)

  The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes (Journal article)

  The inflammatory state in active juvenile rheumatoid arthritis is associated with hypo HDL-EMIA and reduced lipoprotein-associated PAF-acetylhydrolase activity (Journal article)